Activity of tigecycline against coryneform bacteria of clinical interest and Listeria monocytogenes

Antimicrobial Agents and Chemotherapy

Volumn 52, Issue 4, 2008, Pages 1503-1505

  Salas, Carlos ^a   Calvo, Jorge ^a   Martínez Martínez, Luis ^a,b  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b University School of Medicine   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CEFUROXIME; CLINDAMYCIN; DOXYCYCLINE; GENTAMICIN; LEVOFLOXACIN; MINOCYCLINE; TETRACYCLINE; TIGECYCLINE; VANCOMYCIN;

ACTINOMYCETALES; ANTIBACTERIAL ACTIVITY; ARCANOBACTERIUM HAEMOLYTICUM; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CORYNEBACTERIUM; CORYNEBACTERIUM AMYCOLATUM; CORYNEBACTERIUM JEIKEITUM; CORYNEBACTERIUM MINUTISSIMUM; CORYNEBACTERIUM STRIATUM; CORYNEBACTERIUM UREALYTICUM; CORYNEBACTERIUM XEROSIS; DRUG ACTIVITY; DRUG INHIBITION; IN VITRO STUDY; LISTERIA MONOCYTOGENES; NONHUMAN; PRIORITY JOURNAL; RHODOCOCCUS EQUI;

ACTINOMYCETALES; ANTI-BACTERIAL AGENTS; HUMANS; LISTERIA MONOCYTOGENES; MICROBIAL SENSITIVITY TESTS; MINOCYCLINE;

EID: 42049088494     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/AAC.01129-07     Document Type: Article

References (16)

1. Brown, S. D., and M. M. Traczewski. 2007. Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control. J. Clin. Microbiol. 45:2173-2179.
2. Clinical and Laboratory Standards Institute. 2006. Methods for antimicrobial dilution and disk susceptibility testing of infrequently isolated or fastidious bacteria. Approved standard M45-A. Clinical and Laboratory Standards Institute, Wayne, PA.
3. Funke, G., A. von Graevenitz, J. E. Clarridge, and K. A. Bernard. 1997. Clinical significance of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.
4. Goldstein, E. J., D. M. Citron, C. V. Merriam, Y. Warren, and K. Tyrrell. 2000. Comparative in vitro activities of GAR-936 against aerobic and anaerobic animal and human bite wound pathogens. Antimicrob. Agents Chemother. 44:2747-2251.
5. Martínez-Martínez, L. 1998. Clinical significance of newly recognized coryneform bacteria. Rev. Med. Microbiol. 9:55-68.
6. Martínez-Martínez, L., A. Pascual, A. I. Suárez, and E. J. Perea. 1998. In vitro activities of ketolide HMR 3647, macrolides, and clindamycin against coryneform bacteria. Antimicrob. Agents Chemother. 42:3290-3292.
7. Martínez-Martínez, L., A. Pascual, A. I. Suárez, and E. J. Perea. 1999. In vitro activity of levofloxacin, ofloxacin and D-ofioxacin against coryneform bacteria of clinical interest. J. Antimicrob. Chemother. 43(Suppl. C):27-32.
8. Martínez-Martínez, L., A. I. Suárez, J. Winstanley, M. C. Ortega, and K. Bernard. 1995. Phenotypic characteristics of 31 strains of Corynebacterium striatum isolated from clinical samples. J. Clin. Microbiol. 33:2458-2461.
9. Riegel, P., R. Ruimy, R. Christen, and H. Monteil. 1996. Species identities and antimicrobial susceptibilities of corynebacteria isolated from various clinical sources. Eur. J. Clin. Microbiol. Infect. Dis. 15:657-662.
10. Roberts, M. C., R. B. Leonard, A. Briselden, F. D. Schoenknecht, and M. B. Coyle. 1992. Characterization of antibiotic-resistant Corynebacterium striatum strains. J. Antimicrob. Chemother. 30:463-474.
11. Sierra, J. M., L. Martínez-Martínez, F. Vázquez, E. Giralt, and J. Vila. 2005. Relationship between mutations in the gyrA gene and quinolone resistance in clinical isolates of Corynebacterium striatum and Corynebacterium amycolatum. Antimicrob. Agents Chemother. 49:1714-1719.
12. Soriano, F., J. Zapardiel, and N. Nieto. 1995. Antimicrobial susceptibilities of Corynebacterium species and other non-spore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob. Agents Chemother. 39:208-214.
13. Stein, G. E., and W. A. Craig. 2006. Tigecycline: a critical analysis. Clin. Infect. Dis. 43:518-524.
14. Tauch, A., S. Krieft, A. Puhler, and J. Kalinowski. 1999. The tetAB genes of the Corynebacterium striatum R-plasmid pTP10 encode an ABC transporter and confer tetracycline, oxytetracycline and oxacillin resistance in Corynebacterium glutamicum. FEMS Microbiol. Lett. 173:203-209.
15. Tauch, A., A. Puhler, J. Kalinowski, and G. Thierbach. 2000. TetZ, a new tetracycline resistance determinant discovered in gram-positive bacteria, shows high homology to gram-negative regulated efflux systems. Plasmid 44:285-291.
16. Tauch, A., S. Gotker, A. Puhler, J. Kalinowski, and G. Thierbach. 2002. The 27.8-kb R-plasmid pTET3 from Corynebacterium glutamicum encodes the aminoglycoside adenyltransferase gene cassette aadA9 and the regulated tetracycline efflux system Tet 33 flanked by active copies of the widespread insertion sequence IS6100. Plasmid 48:117-129.